Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants

被引:10
作者
Starnino, Stefania [1 ]
Dal Conte, Ivano [2 ]
Matteelli, Alberto [3 ]
Galluppi, Emma [4 ]
Cusini, Marco [5 ]
Di Carlo, Aldo [6 ]
Delmonte, Sergio [7 ]
Stefanelli, Paola [1 ]
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy
[2] Savoia Hosp, STI Clin, Turin, Italy
[3] Univ Brescia, Inst Infect & Trop Dis, I-25121 Brescia, Italy
[4] Univ Bologna, Azienda Osped, Policlin S Orsola Malpighi UO Microbiol, Bologna, Italy
[5] Policlin Mangiagalli Regina Elena, UO Dermatol Fdn, Milan, Italy
[6] San Galilean Dermatol Inst, IRCCS, Rome, Italy
[7] SC Dermosifilopatia 2 ASO US, Turin, Italy
关键词
Neisseria gonorrhoeae; Ciprofloxacin resistance; Molecular analysis; ANTIMICROBIAL RESISTANCE; PREVALENCE; MUTATIONS; PARC; GYRA; RISK;
D O I
10.1016/j.diagmicrobio.2010.03.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 599 Neisseria gonorrhoeae strains collected in Italy in 2 periods, 2003 to 2005 and 2007 to 2008, were screened for ciprofloxacin susceptibility by Etest. Ciprofloxacin-resistant strains (49.7%) were characterized by i) serovar determination, patterns of mutation in gyrA, and parC genes (38%, randomly selected) and ii) N. gonorrhoeae multiantigen sequence typing (56% of the strains isolated from patients who declared their sexual orientation). The percentage of ciprofloxacin-resistant strains increased from 42 (2003-2005) to 58 (2007-2008); in the second period, strains with MIC value >32 mu g/mL have been observed. Mutations in gyrA and parC genes were identified in the majority of strains (88%). Ciprofloxacin-resistant isolates among men who have sex with men (MSM) increased from 24% in 2003 to 2005 to 47% in 2007 to 2008. However, sequence types exclusively found among MSM were mostly due to a single strain. This is the first study in Italy combining N. gonorrhoeae ciprofloxacin susceptibility testing with molecular analyses and comparing the results over time. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:350 / 354
页数:5
相关论文
共 29 条
  • [1] [Anonymous], 2007, MMWR Weekly, V56, P332
  • [2] Antibiotic resistance of Neisseria gonorrhoeae in Spain:: trends over the last two decades
    Arreaza, L
    Salcedo, C
    Alcalá, B
    Berrón, S
    Martín, E
    Vázquez, JA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 153 - 156
  • [3] Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003
    Bauer, HM
    Mark, KE
    Samuel, M
    Wang, SA
    Weismuller, P
    Moore, D
    Gunn, RA
    Peter, C
    Vannier, A
    DeAugustine, N
    Klausner, JD
    Knapp, JS
    Bolan, G
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) : 795 - 803
  • [4] NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES
    BELLAND, RJ
    MORRISON, SG
    ISON, C
    HUANG, WM
    [J]. MOLECULAR MICROBIOLOGY, 1994, 14 (02) : 371 - 380
  • [5] 2009 European (IUSTI/WHO) Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults
    Bignell, C.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (07) : 453 - 457
  • [6] *CDC, 2004, MMWR-MORBID MORTAL W, V53, P335
  • [7] Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India
    Chaudhry, U
    Ray, K
    Bala, M
    Saluja, D
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2002, 78 (06) : 440 - 444
  • [8] *CLSI, 2008, M100S18 CLSI S
  • [9] Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa-implications for treatment guidelines
    De Jongh, Mari
    Dangor, Yusuf
    Adam, Anvir
    Hoosen, Anwar A.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (10) : 697 - 699
  • [10] High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae
    Dewi, BE
    Akira, S
    Hayashi, H
    Ba-Thein, W
    [J]. SEXUALLY TRANSMITTED DISEASES, 2004, 31 (06) : 353 - 359